Offer - Urjas Oil for just ₹ 1 X
Rosumac F Tablet is a prescription medicine that is available as a Tablet. Rosumac F Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Rosumac F Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The side effects typically associated with Rosumac F Tablet include Nausea or vomiting, Headache, Constipation. While these are the most often observed Rosumac F Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Rosumac F Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Rosumac F Tablet's effect is Moderate during pregnancy and Moderate for lactating mothers. It is important to know if Rosumac F Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rosumac F Tablet related warnings section.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Rosumac F Tablet since this can cause severe adverse effects.
Drug interactions for Rosumac F Tablet have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Rosumac F Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Rosumac F Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rosumac F Tablet safe for pregnant women?
Rosumac F may have some side effects during pregnancy. Pregnant women should discontinue the use of Rosumac F, and talk to their doctor, if they notice any discomfort.
Is the use of Rosumac F Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Rosumac F. Immediately discontinue Rosumac F if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Rosumac F Tablet on the Kidneys?
Very few cases of side effects of Rosumac F on kidney have been reported.
What is the effect of Rosumac F Tablet on the Liver?
Rosumac F is rarely harmful for the liver.
What is the effect of Rosumac F Tablet on the Heart?
You may experience side effects on your heart after taking Rosumac F. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Rosumac F Tablet unless your doctor advises you to do so -
Is this Rosumac F Tablet habit forming or addictive?
Forming a habit of Rosumac F Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Rosumac F Tablet. So it is best to avoid driving.
Is it safe?
Yes, but consume Rosumac F Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Rosumac F Tablet is not used to treat mental disorders.
Interaction between Food and Rosumac F Tablet
Due to a lack of research, nothing can be said about the consequences of taking Rosumac F Tablet together with food.
Interaction between Alcohol and Rosumac F Tablet
Due to lack of research, there is no information about the side effects of taking Rosumac F Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650